Diogo Lázaro Fortunato
Postdoctoral researcher
Research Focus:
Curriculum Vitae
Diogo obtained the Master’s degree in Molecular Medicine from Uppsala University (Uppsala, Sweden). He studied the DNA damage response and cancer therapies at the Netherlands Cancer Institute (Amsterdam, The Netherlands) during his Master thesis.
Diogo worked as PhD student and research scientist at the company Exosomics (Siena, Italy), under the umbrella of the Marie Skłodowska-Curie doctoral network European Liquid Biopsies Academy (ELBA). He was awarded the PhD title in Genetics, Oncology and Clinical Medicine from the University of Siena (Siena, Italy). His research focused on liquid biopsies and extracellular vesicles as circulating biomarkers for early-stage lung cancer detection.
Currently, Diogo works at the Exosome Research Group (Michiel Pegtel) and the Neuroimmunology Research Group (Elga de Vries), to understand how extracellular vesicles cross the blood-brain barrier and how they can be leveraged as drug delivery vehicles.
Postdoctoral researcher
Research Focus:
- Single Extracellular Vesicle (EV) characterization and quantification by nano flow
- Transport of EVs across the blood-brain barrier
- Human induced pluripotent stem cell-derived EVs and in vitro models
Curriculum Vitae
Diogo obtained the Master’s degree in Molecular Medicine from Uppsala University (Uppsala, Sweden). He studied the DNA damage response and cancer therapies at the Netherlands Cancer Institute (Amsterdam, The Netherlands) during his Master thesis.
Diogo worked as PhD student and research scientist at the company Exosomics (Siena, Italy), under the umbrella of the Marie Skłodowska-Curie doctoral network European Liquid Biopsies Academy (ELBA). He was awarded the PhD title in Genetics, Oncology and Clinical Medicine from the University of Siena (Siena, Italy). His research focused on liquid biopsies and extracellular vesicles as circulating biomarkers for early-stage lung cancer detection.
Currently, Diogo works at the Exosome Research Group (Michiel Pegtel) and the Neuroimmunology Research Group (Elga de Vries), to understand how extracellular vesicles cross the blood-brain barrier and how they can be leveraged as drug delivery vehicles.